TickerStat.com

Latigo Biotherapeutics, Inc. (LTGO)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$4,000$2.0M
Research & development$3.0M$1.3M
Net income$2.0M$2.0M
Diluted EPSper diluted share$2,025.00$2,024.00
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗